Basics Affimed N.V. Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells. IPO Date: September 12, 2014 Sector: Healthcare Industry: Biotech Market Cap: $2.13M Activated in VL: False Average Daily Range Avg Daily Range: $0.14 | 3.67% Avg Daily Range (30 D): $0.05 | 9.61% Avg Daily Range (90 D): $0.03 | 5.28% Institutional Daily Volume Avg Daily Volume: 1.01M Avg Daily Volume (30 D): 25.05M Avg Daily Volume (90 D): 8.6M Trade Size Avg Trade Size (Sh.): 264 Avg Trade Size (Sh.) (30 D): 1,102 Avg Trade Size (Sh.) (90 D): 1,073 Institutional Trades Total Inst.Trades: 324 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.81M Avg Inst. Trade (90 D): $.81M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 40.89K         News No news available.